These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 15630497

  • 1. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D.
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [Abstract] [Full Text] [Related]

  • 2. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.
    J Stroke Cerebrovasc Dis; 2007 Jan; 16(4):153-9. PubMed ID: 17689411
    [Abstract] [Full Text] [Related]

  • 3. The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population.
    Akhter MS, Biswas A, Abdullah SM, Behari M, Saxena R.
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):1071-1076. PubMed ID: 28460568
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
    Wiklund PG, Nilsson L, Ardnor SN, Eriksson P, Johansson L, Stegmayr B, Hamsten A, Holmberg D, Asplund K.
    Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
    [Abstract] [Full Text] [Related]

  • 5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 6. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 7. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.
    Chen CH, Eng HL, Chang CJ, Tsai TT, Lai ML, Chen HY, Liu CJ, Lin TM.
    J Lab Clin Med; 2003 Aug; 142(2):100-5. PubMed ID: 12960956
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
    Ding J, Nicklas BJ, Fallin MD, de Rekeneire N, Kritchevsky SB, Pahor M, Rodondi N, Li R, Zmuda JM, Harris TB.
    Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
    [Abstract] [Full Text] [Related]

  • 9. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
    Adamski MG, Turaj W, Slowik A, Wloch-Kopec D, Wolkow P, Szczudlik A.
    Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
    [Abstract] [Full Text] [Related]

  • 10. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
    Boncoraglio GB, Bodini A, Brambilla C, Carriero MR, Ciusani E, Parati EA.
    Cerebrovasc Dis; 2006 Aug; 22(2-3):191-5. PubMed ID: 16735791
    [Abstract] [Full Text] [Related]

  • 11. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C.
    Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
    [Abstract] [Full Text] [Related]

  • 12. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
    Sartori MT, Vettor R, De Pergola G, De Mitrio V, Saggiorato G, Della Mea P, Patrassi GM, Lombardi AM, Fabris R, Girolami A.
    Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 14. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
    Hoekstra T, Geleijnse JM, Kluft C, Giltay EJ, Kok FJ, Schouten EG.
    Stroke; 2003 Dec 01; 34(12):2822-8. PubMed ID: 14605330
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, Saxena R.
    Clin Appl Thromb Hemost; 2010 Apr 01; 16(2):184-8. PubMed ID: 19419975
    [Abstract] [Full Text] [Related]

  • 16. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM, Ostriakova EV, Patrusheva NL, Patrushev LI, Aleksandrova EN, Seredavkina NV, Volkov AV, Nasonov EL.
    Ter Arkh; 2013 Apr 01; 85(1):76-84. PubMed ID: 23536951
    [Abstract] [Full Text] [Related]

  • 17. GLU298ASP and 4G/5G Polymorphisms and the Risk of Ischemic Stroke in Young Individuals.
    Esparza-García JC, Santiago-Germán D, Guadalupe Valades-Mejía M, Hernández-Juárez J, Aguilar-Sosa E, Leaños-Miranda A, Alvarado-Moreno A, Majluf-Cruz A, Isordia-Salas I.
    Can J Neurol Sci; 2015 Sep 01; 42(5):310-6. PubMed ID: 26036781
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.
    Catto AJ, Carter AM, Stickland M, Bamford JM, Davies JA, Grant PJ.
    Thromb Haemost; 1997 Apr 01; 77(4):730-4. PubMed ID: 9134651
    [Abstract] [Full Text] [Related]

  • 19. Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke.
    Natesirinilkul R, Sasanakul W, Chuansumrit A, Kadegasem P, Visudtibhan A, Wongwerawattanakoon P, Sirachainan N.
    J Stroke Cerebrovasc Dis; 2014 Apr 01; 23(10):2566-2572. PubMed ID: 25284719
    [Abstract] [Full Text] [Related]

  • 20. 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.
    Burzotta F, Iacoviello L, Di Castelnuovo A, Zamparelli R, D'Orazio A, Amore C, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F.
    J Thromb Thrombolysis; 2003 Dec 01; 16(3):149-54. PubMed ID: 15087600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.